On the mechanism of the anti-androgenic action of flutamide (alpha-alpha-alpha-trifluoro-2-methyl-4'-nitro-m-propionotoluidide) in the rat.
D000726:Androgen Antagonists; D000813:Anilides / Q000008:administration & dosage / Q000494:pharmacology*; D000818:Animals; D003534:Cyproterone / Q000494:pharmacology; D013196:Dihydrotestosterone / Q000378:metabolism*; D006845:Hydrocarbons, Fluorinated / Q000008:administration & dosage / Q000494:pharmacology; D008297:Male; D009574:Nitro Compounds / Q000008:administration & dosage / Q000494:pharmacology; D011467:Prostate / Q000378:metabolism*; D051381:Rats; D012669:Seminal Vesicles / Q000378:metabolism*; D013739:Testosterone / Q000037:antagonists & inhibitors / Q000378:metabolism*; D014316:Tritium
D000726:Androgen Antagonists; D000813:Anilides; D006845:Hydrocarbons, Fluorinated; D009574:Nitro Compounds; D013196:Dihydrotestosterone; D014316:Tritium; D013739:Testosterone; D003534:Cyproterone